FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587313190> ?p ?o ?g. }

• W2587313190 endingPage "1090" @default.
• W2587313190 startingPage "1090" @default.
• W2587313190 abstract "To evaluate the feasibility of chemotherapy including fluoropyrimidine, platinum and taxane with modified dosages for unresectable gastric cancer in Japanese patients.We performed a feasibility study of a modified docetaxel, cisplatin and capecitabine (DCX) regimen for stage IV gastric cancer. In particular, 30 or 40 mg/m2 of docetaxel on day 1, 60 mg/m2 of cisplatin on day 1, and 2000 mg/m2 of capecitabine for 2 wk were administered every three weeks.Three patients were treated with modified DCX (mDCX) with 30 mg/m2 docetaxel, and five patients were treated with this regimen with 40 mg/m2 docetaxel. Grade 3 or 4 neutropenia was observed in six of the eight patients; no patients exhibited febrile neutropenia. Partial response was achieved in four of the eight patients. Three patients underwent gastrectomy, which achieved R0 resection without residual tumors in dissected lymph nodes. In one of these three patients, resected specimens revealed pathological complete response in the primary lesion and in lymph nodes.mDCX was well tolerated by Japanese patients with stage IV gastric cancer. This regimen might be useful for allowing gastric cancer patients with distant lymph node metastasis to undergo conversion surgery." @default.
• W2587313190 created "2017-02-17" @default.
• W2587313190 creator A5015317828 @default.
• W2587313190 creator A5018146056 @default.
• W2587313190 creator A5048279225 @default.
• W2587313190 creator A5048728798 @default.
• W2587313190 creator A5053475533 @default.
• W2587313190 creator A5059713499 @default.
• W2587313190 creator A5062974142 @default.
• W2587313190 creator A5071579046 @default.
• W2587313190 creator A5073682958 @default.
• W2587313190 creator A5084402247 @default.
• W2587313190 date "2017-01-01" @default.
• W2587313190 modified "2023-10-17" @default.
• W2587313190 title "Modified docetaxel, cisplatin and capecitabine for stage IV gastric cancer in Japanese patients: A feasibility study" @default.
• W2587313190 cites W1975099907 @default.
• W2587313190 cites W1975188052 @default.
• W2587313190 cites W1977629257 @default.
• W2587313190 cites W1998819621 @default.
• W2587313190 cites W2015463293 @default.
• W2587313190 cites W2024294177 @default.
• W2587313190 cites W2029487834 @default.
• W2587313190 cites W2079842887 @default.
• W2587313190 cites W2082189234 @default.
• W2587313190 cites W2107840962 @default.
• W2587313190 cites W2114592324 @default.
• W2587313190 cites W2122866527 @default.
• W2587313190 cites W2157206044 @default.
• W2587313190 cites W2167369158 @default.
• W2587313190 cites W2171075804 @default.
• W2587313190 cites W2177986043 @default.
• W2587313190 cites W2189924230 @default.
• W2587313190 cites W2417931553 @default.
• W2587313190 doi "https://doi.org/10.3748/wjg.v23.i6.1090" @default.
• W2587313190 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5311098" @default.
• W2587313190 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28246483" @default.
• W2587313190 hasPublicationYear "2017" @default.
• W2587313190 type Work @default.
• W2587313190 sameAs 2587313190 @default.
• W2587313190 citedByCount "7" @default.
• W2587313190 countsByYear W25873131902017 @default.
• W2587313190 countsByYear W25873131902018 @default.
• W2587313190 countsByYear W25873131902019 @default.
• W2587313190 countsByYear W25873131902021 @default.
• W2587313190 countsByYear W25873131902023 @default.
• W2587313190 crossrefType "journal-article" @default.
• W2587313190 hasAuthorship W2587313190A5015317828 @default.
• W2587313190 hasAuthorship W2587313190A5018146056 @default.
• W2587313190 hasAuthorship W2587313190A5048279225 @default.
• W2587313190 hasAuthorship W2587313190A5048728798 @default.
• W2587313190 hasAuthorship W2587313190A5053475533 @default.
• W2587313190 hasAuthorship W2587313190A5059713499 @default.
• W2587313190 hasAuthorship W2587313190A5062974142 @default.
• W2587313190 hasAuthorship W2587313190A5071579046 @default.
• W2587313190 hasAuthorship W2587313190A5073682958 @default.
• W2587313190 hasAuthorship W2587313190A5084402247 @default.
• W2587313190 hasBestOaLocation W25873131901 @default.
• W2587313190 hasConcept C121608353 @default.
• W2587313190 hasConcept C126322002 @default.
• W2587313190 hasConcept C141071460 @default.
• W2587313190 hasConcept C143998085 @default.
• W2587313190 hasConcept C2776694085 @default.
• W2587313190 hasConcept C2777063308 @default.
• W2587313190 hasConcept C2777511904 @default.
• W2587313190 hasConcept C2777909004 @default.
• W2587313190 hasConcept C2778239845 @default.
• W2587313190 hasConcept C2778850193 @default.
• W2587313190 hasConcept C2780470880 @default.
• W2587313190 hasConcept C2781190966 @default.
• W2587313190 hasConcept C2781413609 @default.
• W2587313190 hasConcept C526805850 @default.
• W2587313190 hasConcept C530470458 @default.
• W2587313190 hasConcept C71924100 @default.
• W2587313190 hasConcept C90924648 @default.
• W2587313190 hasConceptScore W2587313190C121608353 @default.
• W2587313190 hasConceptScore W2587313190C126322002 @default.
• W2587313190 hasConceptScore W2587313190C141071460 @default.
• W2587313190 hasConceptScore W2587313190C143998085 @default.
• W2587313190 hasConceptScore W2587313190C2776694085 @default.
• W2587313190 hasConceptScore W2587313190C2777063308 @default.
• W2587313190 hasConceptScore W2587313190C2777511904 @default.
• W2587313190 hasConceptScore W2587313190C2777909004 @default.
• W2587313190 hasConceptScore W2587313190C2778239845 @default.
• W2587313190 hasConceptScore W2587313190C2778850193 @default.
• W2587313190 hasConceptScore W2587313190C2780470880 @default.
• W2587313190 hasConceptScore W2587313190C2781190966 @default.
• W2587313190 hasConceptScore W2587313190C2781413609 @default.
• W2587313190 hasConceptScore W2587313190C526805850 @default.
• W2587313190 hasConceptScore W2587313190C530470458 @default.
• W2587313190 hasConceptScore W2587313190C71924100 @default.
• W2587313190 hasConceptScore W2587313190C90924648 @default.
• W2587313190 hasIssue "6" @default.
• W2587313190 hasLocation W25873131901 @default.
• W2587313190 hasLocation W25873131902 @default.
• W2587313190 hasLocation W25873131903 @default.
• W2587313190 hasLocation W25873131904 @default.
• W2587313190 hasOpenAccess W2587313190 @default.
• W2587313190 hasPrimaryLocation W25873131901 @default.

• next